125 related articles for article (PubMed ID: 4114753)
1. Cyclophosphamide plus emetine in lung cancer.
Street EW
Lancet; 1972 Aug; 2(7773):381-2. PubMed ID: 4114753
[No Abstract] [Full Text] [Related]
2. Cyclophosphamide plus emetine in lung cancer.
Hyde KR; Marsh K; Perry W
Lancet; 1972 Aug; 2(7774):427. PubMed ID: 4115244
[No Abstract] [Full Text] [Related]
3. [Prognostic factors in the chemotherapy of bronchial cancers].
Alberto P
Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
[No Abstract] [Full Text] [Related]
4. Phase I-II evaluation of emetine (NSC-33669) in the treatment of epidermoid bronchogenic carcinoma.
Kane RC; Cohen MH; Broder LE; Bull MI; Creaven PJ; Fossieck BE
Cancer Chemother Rep; 1975; 59(6):1171-2. PubMed ID: 1222395
[No Abstract] [Full Text] [Related]
5. Chemotherapy of bronchogenic carcinomas by a combination of cyclophosphamide, methotrexate, vincristin and bleomycin.
Schaerer R; Sotto JJ; Wiget U; Perdrix A; Bensa JC; Ribaud P
Eur J Cancer (1965); 1977; 13(4-5):425-8. PubMed ID: 68881
[No Abstract] [Full Text] [Related]
6. Heparin anticoagulation as adjuvant to chemotherapy in carcinoma of the lung.
Elias EG
J Med; 1974; 5(1):114-32. PubMed ID: 4364885
[No Abstract] [Full Text] [Related]
7. Experience with emetine hydrochloride (NSC 33669) as an antitumor agent.
Panettiere F; Coltman CA
Cancer; 1971 Apr; 27(4):835-41. PubMed ID: 4929936
[No Abstract] [Full Text] [Related]
8. Combination chemotherapy of advanced non-oat cell carcinoma of the lung.
Richards F; White DR; Muss HB; Jackson DV; Stuart JJ; Cooper MR; Rhyne L; Spurr CL
Cancer; 1979 Nov; 44(5):1576-81. PubMed ID: 227571
[No Abstract] [Full Text] [Related]
9. Effect of CCNU (NSC-79037) on bronchogenic carcinoma.
Takita H; Brugarolas A
J Natl Cancer Inst; 1973 Jan; 50(1):49-53. PubMed ID: 4348225
[No Abstract] [Full Text] [Related]
10. Methotrexate in the chemotherapy of lung cancer.
Smyth JF; Ford HT
Cancer Treat Rep; 1981; 65 Suppl 1():161-3. PubMed ID: 6275986
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
Curtis JE
Cancer Chemother Rep; 1974; 58(6):883-8. PubMed ID: 4614897
[No Abstract] [Full Text] [Related]
12. Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.
Morgan LR; Posey LE; Rainey J; Bickers J; Ryan D; Vial R; Hull EW
Cancer Treat Rep; 1981; 65(7-8):693-5. PubMed ID: 6265084
[No Abstract] [Full Text] [Related]
13. Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine.
Alberto P; Brunner KW; Martz G; Obrecht J; Sonntag RW
Cancer; 1976 Dec; 38(6):2208-16. PubMed ID: 187313
[TBL] [Abstract][Full Text] [Related]
14. Lung cancer: perspectives and prospects.
Ann Intern Med; 1970 Dec; 73(6):1003-24. PubMed ID: 4336754
[No Abstract] [Full Text] [Related]
15. Cyclophosphamide in disseminated bronchial carcinoma.
Cameron SJ; Grant IW; Crompton GK
Scott Med J; 1974 Mar; 19(2):81-6. PubMed ID: 4365318
[No Abstract] [Full Text] [Related]
16. [Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
González Larriba JL; Ordóñez Gallego A; Díaz Pérez MA; García de Paredes ML; Zamora P; Montero García JM
Med Clin (Barc); 1984 May; 82(19):836-9. PubMed ID: 6330470
[No Abstract] [Full Text] [Related]
17. Management of mediastinal compression due to bronchogenic carcinoma.
Anand AK; Ayyagari S; Sharma SC; Patel FD; Gupta BD
Acta Radiol Oncol; 1985; 24(3):233-5. PubMed ID: 2994372
[TBL] [Abstract][Full Text] [Related]
18. [Cytostatic therapy of tumors of the lung].
De Marco F; Saviano G; Tenore G
Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917
[No Abstract] [Full Text] [Related]
19. Combination chemotherapy for bronchogenic carcinoma with doxorubicin, BCNU, and cyclophosphamide (ABC): a pilot study of the Southeastern Cancer Study Group.
Denes AE; Presant CA; Bartolucci A
Cancer Treat Rep; 1982 Jan; 66(1):199-200. PubMed ID: 7053258
[No Abstract] [Full Text] [Related]
20. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
Ryssel HJ; Hasler E; Sonntag RW; Cavalli F; Martin J; Tschopp L; Brunner KW
Schweiz Med Wochenschr; 1977 Jul; 107(26):912-5. PubMed ID: 877537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
